CN Patent

CN109879804B — 5-杂环取代吡啶-2-甲酰甘氨酸化合物、其制法和医药用途

Assigned to China Pharmaceutical University · Expires 2022-06-17 · 4y expired

What this patent protects

本发明涉及药物化学领域。具体涉及一类5‑杂环取代吡啶‑2‑甲酰甘氨酸化合物(I)以及含有这类化合物的药物组合物、其制备方法，药效学试验证明，本发明的化合物具有脯氨酰羟化酶抑制剂功效，可用于治疗贫血症、缺血性等疾病。

USPTO Abstract

本发明涉及药物化学领域。具体涉及一类5‑杂环取代吡啶‑2‑甲酰甘氨酸化合物(I)以及含有这类化合物的药物组合物、其制备方法，药效学试验证明，本发明的化合物具有脯氨酰羟化酶抑制剂功效，可用于治疗贫血症、缺血性等疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN109879804B
Jurisdiction
CN
Classification
—
Expires
2022-06-17
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.